Dianthus Therapeutics | Kapitał Własny I Rezerwy



Equity Capital And Reserves Zmiana Data
Adcock Ingram Holdings ZAR 5.54B 131.19M 2024-12
Alaunos Therapeutics USD 2.06M 661K 2024-12
Avita Medical AUD 4.5M 19.42M 2024-12
Celltrion KRW 17.14T 16.74T 2025-03
Cspc Pharmaceutical CNY 32.26B 2.59B 2024-12
Dianthus Therapeutics USD 352.48M 14.58M 2024-12
Divis Laboratories Ltd 149.69B 12.52B 2025-03
IQVIA Holdings USD 5.98B 90M 2025-03
Kangmei Pharma CNY 7.04B 22.02M 2024-09
Knight Therapeutics CAD 773.91M 11.11M 2024-09
Laboratorios Farma EUR 581.54M 98.78M 2024-12
Malin Corporation EUR 118.2M 8.7M 2024-06
Medical Developments International AUD 45.73M 29.96M 2024-06
Moderna USD 10.07B 835M 2025-03
Neuren Pharmaceuticals AUD 363.9M 144.75M 2024-12
Organigram Holdings CAD 323.65M 17.66M 2024-12
Organon & Co USD 542M 70M 2025-03
Pharma Mar EUR 197.47M 10.89M 2025-03
Qiagen NV USD 3.57B 37.35M 2024-12
Revvity USD 7.64B 29.74M 2025-03
Sartorius EUR 2.71B 1.19B 2025-03
Sino Biopharmaceutical CNY 31.96B 10.16B 2024-12
Tectonic Therapeutic USD 140.78M 9.58M 2024-12
Tilray USD 3.47B 5.16M 2024-11
Viatris USD 15.65B 2.99B 2025-03
Xeris Pharmaceuticals USD -29615000 1.29M 2024-12
Zz Pientze Pharmaceu 15.26B 991.2M 2025-03



Dianthus Therapeutics Kapitał Własny I Rezerwy - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.